Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: February 28, 2013
Reporting Period: Fourth quarter and full year ended December 31, 2012.
This filing serves as a notification that the Company issued a press release announcing financial results for the specified period. The detailed results are contained in Exhibit 99.1 and are incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not listed within the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the fourth quarter and full year ended December 31, 2012.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on February 28, 2013, which contains the Company's commentary on operations and financial condition.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2012.
- Verify year-over-year growth rates and margin trends detailed in the press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the status of the Company's liquidity and debt obligations as described in the full financial report.